| Identification | Back Directory | [Name]
N-[3-[6-(4-methylpiperazin-1-yl)pyridazin-3-yl]phenyl]naphthalene-2-carboxamide | [CAS]
899759-16-1 | [Synonyms]
MLKL-IN-2
N-[3-[6-(4-methylpiperazin-1-yl)pyridazin-3-yl]phenyl]naphthalene-2-carboxamide | [Molecular Formula]
C26H25N5O | [MOL File]
899759-16-1.mol | [Molecular Weight]
423.51 |
| Hazard Information | Back Directory | [Uses]
MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i)[1]. | [Biological Activity]
MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i)[1]. | [storage]
Store at -20°C | [References]
[1]. Sáez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1. |
|
|